Abstract:Circulation: Cardiovascular Imaging, Ahead of Print. BACKGROUND:The presence and clinical significance of hepatic tissue alterations as assessed by cardiac magnetic resonance imaging in patients with ST-segment–elevation myocardial infarction (STEMI), are unclear. This study aimed to investigate associations of hepatic T1 patterns with myocardial tissue damage and clinical outcomes in patients suffering from STEMI.METHODS:We analyzed 485 patients with STEMI treated with percutaneous coronary intervention who were enrolled in the prospective magnetic resonance imaging in acute ST-elevation myocardial infarction study (MARINA STEMI). Myocardial function and left and right ventricular (RV) infarct characteristics were assessed by cardiac magnetic resonance within the first week after STEMI. Native hepatic T1 times and extracellular volume were evaluated from standard cardiac T1 maps at baseline and 4 months thereafter.RESULTS:Median hepatic T1 times were 559 ms (interquartile range, 514–605) at baseline and decreased to 542 ms (interquartile range, 507–577) at 4 months (P<0.001). Hepatic T1 times at baseline were independently associated with female sex (β 0.116;P=0.008), hyperlipidemia (β −0.116;P=0.008), and myocardial tissue damage (infarct size: β 0.178;P<0.001; microvascular obstruction: β 0.193;P<0.001; RV infarction: β 0.161;P<0.001). Determinants of hepatic T1 times at 4 months were female sex (β 0.123;P=0.002), multivessel disease (β 0.121;P=0.002), N-terminal pro–B-type natriuretic peptide (β 0.101;P=0.010), RV infarction (β 0.501;P<0.001), and RV end-systolic volume index (β 0.087;P=0.031). Patients without a decrease exhibited a higher frequency of major adverse cardiovascular events (13% versus 5%;P=0.003). Hepatic T1 times at baseline (hazard ratio, 1.87 [95% CI, 1.40–2.50];P<0.001), 4 months (hazard ratio, 2.69 [95% CI, 2.15–3.36];P<0.001), and hepatic extracellular volume at 4 months (hazard ratio, 1.59 [95% CI, 1.33–1.90];P<0.001) were associated with major adverse cardiovascular events. After adjustment for univariable associates, only hepatic T1 times at 4 months were independently associated with adverse outcomes (hazard ratio, 2.86 [95% CI, 1.99–4.12];P<0.001).CONCLUSIONS:Hepatic tissue alterations determined by T1 mapping were associated with female sex, hyperlipidemia, multivessel disease, N-terminal pro–B-type natriuretic peptide, and left and RV myocardial tissue damage. These alterations can persist into the chronic phase after STEMI and indicate a worse clinical outcome.REGISTRATION:URL:https://www.clinicaltrials.gov; Unique identifier: NCT04113356.

Hypertension, Microvascular Obstruction and Infarct Size in Patients with STEMI Undergoing PCI: Pooled Analysis from 7 Cardiac Magnetic Resonance Imaging Studies

Impact of hypertension on mortality in patients with ST-elevation myocardial infarction undergoing primary angioplasty: insights from the international multicenter ISACS-STEMI registry

Clinical Outcomes in Patients With ST-Segment Elevation MI and No Standard Modifiable Cardiovascular Risk Factors

Association of maximal systolic blood pressure with poor outcome in patients with hyperattenuated lesions on immediate NCCT after mechanical thrombectomy.

Reassess Hospital Costs and Mortality Between Myocardial Infarction With and Without ST‐Segment Elevation in a Modern Context

Relationship Between Infarct Artery, Myocardial Injury, and Outcomes After Primary Percutaneous Coronary Intervention in ST-Segment-Elevation Myocardial Infarction

Impact of Early Revascularization on Major Adverse Cardiovascular Events in Relation to Automatically Quantified Ischemia

Clinical, electrocardiographic, echocardiographic, and angiographic predictors for the final infarct size assessed by cardiac magnetic resonance in acute STEMI patients after primary percutaneous coronary intervention

Prevalence and associated factors of mortality after percutaneous coronary intervention for adult patients with ST-elevation myocardial infarction: A systematic review and meta-analysis

Central arterial pressure predicts in-hospital major adverse cardiovascular events after acute ST-segment elevation myocardial infarction: a retrospective cohort study

Factors Associated with Microvascular Occlusion in Patients with ST Elevation Myocardial Infarction after Primary Percutaneous Coronary Intervention.

Clinical Outcomes Associated With Various Microvascular Injury Patterns Identified by CMR After STEMI

Acute Response in the Noninfarcted Myocardium Predicts Long-Term Major Adverse Cardiac Events After STEMI

RELATIONSHIP OF SUBENDOCARDIAL PERFUSION TO MYOCARDIAL INJURY, LV REMODELING, AND CLINICAL OUTCOMES IN PATIENTS WITH HYPERTENSION

Relationship of Subendocardial Perfusion to Myocardial Injury, Cardiac Structure, and Clinical Outcomes Among Patients With Hypertension

Ischemia From Nonculprit Stenoses Is Not Associated With Reduced Culprit Infarct Size in Patients with ST-Segment-Elevation Myocardial Infarction

Assessment of microvascular occlusion in re-perfused myocardial infarction patients using cardiac magnetic resonance

Clinical and angiographic characteristics of out-of-hospital cardiac arrest among patients with ST-segment elevation myocardial infarction

Hepatic Tissue Alterations in ST-Elevation Myocardial Infarction: Determinants and Prognostic Implications

Long-Term Clinical Outcomes in Patients With an Acute ST-Segment-Elevation Myocardial Infarction Stratified by Angiography-Derived Index of Microcirculatory Resistance

Prevalence and Outcomes of Patients With Acute Ischemic Stroke With Concomitant ST–Elevation Myocardial Infarction (Results From National Inpatient Sample 2016–2019)